Advent increases stake in Argentine lab

Advent increases stake in Argentine lab

Argentina Funds M&A

Advent International-owned biopharmaceutical firm Grupo Biotoscana has bought Argentina’s Laboratorio LKM, the private equity fund said. Advent previously owned a controlling stake in LKM.  The new entity, with combined revenues of $250m, will

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial